IRS - Sygehus Lillebælt, Forskningsenhed for Gynækologi og Obstetrik (Kolding)

Medicin og biovidenskab

1. Streptococcus agalactiae 100%
2. Pregnancy 63%
3. Denmark 47%
4. Parturition 30%
5. Polymerase Chain Reaction 29%
6. Pregnant Women 24%
7. Down Syndrome 23%
8. Mothers 22%
9. Cesarean Section 21%
10. Urine 20%
11. Gestational Age 19%
12. Gestational Diabetes 18%
13. First Pregnancy Trimester 16%
14. Antibiotic Prophylaxis 14%
15. Pre-Eclampsia 14%
16. Child 13%
17. Elasticity Imaging Techniques 13%
18. Cohort Studies 12%
19. Leisure Activities 12%
20. HELLP Syndrome 11%
21. Bacteriuria 11%
22. Twins 11%
23. Population 11%
24. Anti-Bacterial Agents 11%
25. Prolonged Pregnancy 10%
26. Fetus 10%
27. Streptococcus 9%
28. Risk Assessment 9%
29. Body Mass Index 9%
30. Fetal Version 8%
31. Sex Chromosome Aberrations 8%
32. Cross-Sectional Studies 8%
33. Infections 8%
34. Prenatal Diagnosis 8%
35. Obesity 8%
36. Pseudoxanthoma Elasticum 8%
37. Iron-Deficiency Anemias 8%
38. Motor Skills Disorders 8%
39. Postpartum Period 7%
40. Randomized Controlled Trials 7%
41. Posterior Leukoencephalopathy Syndrome 7%
42. Dystocia 7%
43. Coronavirus Infections 7%
44. Pragmatic Clinical Trials 7%
45. Pregnancy-Associated Plasma Protein-A 7%
46. Abnormal Karyotype 7%
47. Terbutaline 7%
48. Negative-Pressure Wound Therapy 7%
49. Fabry Disease 7%
50. Abruptio Placentae 7%
51. Maternal Age 7%
52. Guidelines 7%
53. Fetal Alcohol Spectrum Disorders 7%
54. Osteogenesis Imperfecta 7%
55. Enzyme Replacement Therapy 7%
56. Fatty Acid-Binding Proteins 7%
57. Severe Acute Respiratory Syndrome 6%
58. Colposcopy 6%
59. Twin Studies 6%
60. Carotid Artery Diseases 6%
61. Odds Ratio 6%
62. Uterine Hemorrhage 6%
63. Muscular Atrophy 6%
64. Interviews 6%
65. Arteriovenous Malformations 6%
66. Prospective Studies 6%
67. Hemorrhage 6%
68. Health 6%
69. Elasticity 6%
70. Surgical Wound Infection 6%
71. Self-Management 5%
72. Endometriosis 5%
73. Contraceptive Agents 5%
74. Premature Birth 5%
75. Live Birth 5%
76. Iron 5%
77. Contraception 5%
78. Genetic Testing 5%
79. Rectal Neoplasms 5%
80. Hypersensitivity 5%
81. Carbon Monoxide 5%
82. Mortality 5%
83. Breast Feeding 5%
84. Medicine 5%
85. Saliva 5%
86. Overweight 5%
87. Hepatitis B 5%
88. Tocolysis 5%
89. Nuchal Translucency Measurement 5%
90. Vitamin D 5%
91. Case-Control Studies 5%
92. Genitalia 5%